The report on Global Carcinoid Tumor Market evaluates the growth trends of the industry through historical study and estimates future prospects based on comprehensive research. and it is also includes 90 pages, Full TOC, List of Tables, List of Figures and many features such as Report Prologue, Market Introduction, Research Methodology, Market Dynamics, Market Factor Analysis, and Global Carcinoid Tumor Market by (type, Products, End User and Region), Company Landscape, Company Profiles, MRFR Conclusion and Worldwide Forecast up to 2023
Pune, India -- (SBWIRE) -- 03/19/2018 -- Global carcinoid tumor market is expected to grow at an approximate of CAGR of 10.5% during forecast period. The other sites for the development of the carcinoid tumors is inclusive of the pancreas, testicles, and ovaries. According to the American Society of Clinical Oncology (ASCO) in 2016, approximately 8,000 adults in the US were diagnosed with a carcinoid tumor in their GI tract.
Moreover, it was also estimated that each year approximately 4,000 adults in the United States diagnose with the carcinoid tumor in their lung. Thus, the prevalence of the carcinoid tumor is expected to drive the market. In 2016, American Society of Clinical Oncology (ASCO) published a report stating that the people who were diagnosed with carcinoid tumor were in their early 60s. Additionally, according to the report of WHO published in 2015, the geriatric population is expected to double and reach 2.1 billion by 2050. Thus, the growing geriatric population along with rising healthcare expenditure is set to boost the market growth during the forecast period. However, lack of awareness, treatment cost and related side effects may restrain the market growth during the forecast period.
Access Sample Copy @ https://www.marketresearchfuture.com/sample_request/4813 .
America dominates the global carcinoid tumor market owing to a well-developed healthcare sector and huge patient population. Apart from this, increasing healthcare expenditure and presence of developed economies within the region are adding fuel to the growth of the market in America.
Europe is the second leading region in the global carcinoid tumor market, which is followed by Asia Pacific. Availability of funds for research, huge patient population and government support for research & development are projected to drive the market. According to the National Health Service in 2015, each year about 1,200 people diagnose with carcinoid tumor in the UK.
Carcinoid Tumor Market is expected to grow at an approximate of CAGR of 10.5% during forecast period. Carcinoid tumor is a type of the neuroendocrine tumor. A neuroendocrine tumor develops in the body's neuroendocrine system, which is made up of cells that are a combination of hormone-producing endocrine cells and nerve cells. The most common site of carcinoid tumors is GI (gastrointestinal) tract and lungs.
Market Highlights:
Carcinoid tumor is a type of the neuroendocrine tumor. The most common site of carcinoid tumors is the GI (gastrointestinal) tract and the lungs. However, it can also be developed in pancreas, testicles, and ovaries. The increasing prevalence of the carcinoid tumor is expected to drive the market growth. According to the American Society of Clinical Oncology (ASCO) in 2016, approximately 8,000 adults in the US were diagnosed with a carcinoid tumor in their GI tract. Moreover, it was also estimated that each year approximately 4,000 adults in the US are diagnosed with a carcinoid tumor in their lung. Moreover, growing geriatric population along with rising healthcare expenditure is likely to boost the market growth during the forecast period. However, lack of awareness, high treatment cost and related side effects may hamper the market growth during the forecast period.
Get Discount on Carcinoid Tumor Market Report @ https://www.marketresearchfuture.com/check-discount/4813 .
Key Players are:
Novartis AG (Europe),
Amgen Inc. (U.S.),
Boehringer Ingelheim GmbH (Europe),
AVEO Pharmaceuticals, Inc. (U.S.),
Chiasma, Inc. (U.S.), Aegis Therapeutics,
LLC (U.S.)
And others.
Table of Content:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
And more…
LIST OF TABLES
Table 1 Cancer Industry Synopsis, 2017 – 2023
Table 2 Global Carcinoid Tumor Market Estimates And Forecast, 2017 – 2023, (USD Million)
Table 3 Global Carcinoid Tumor Market By Region, 2017 – 2023, (USD Million)
Table 4 Global Carcinoid Tumor Market By Site, 2017 – 2023, (USD Million)
Table 5 Global Carcinoid Tumor Market By Diagnosis, 2017 – 2023, (USD Million)
And more…
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation For Global Carcinoid Tumor Market
Figure 3 Segmentation Market Dynamics For Global Carcinoid Tumor Market
Figure 4 Global Carcinoid Tumor Market Share, By Site 2016
Figure 5 Global Carcinoid Tumor Market Share, By Diagnosis 2016
And more…
Access Report Details @ https://www.marketresearchfuture.com/reports/carcinoid-tumor-market-4813
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com